GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- Research and development, FY2025
- £7.5B
- YoY, FY2025
- +17.6%
- 5-year CAGR
- +9.4%
- 10-year CAGR
- +7.8%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| FY2025 | £7.5B | +17.6% |
| FY2024 | £6.4B | +2.9% |
| FY2023 | £6.2B | +13.4% |
| FY2022 | £5.5B | +9.3% |
| FY2021 | £5.0B | +4.7% |
| FY2020 | £4.8B | +4.9% |
| FY2019 | £4.6B | +17.3% |
| FY2018 | £3.9B | −13.0% |
| FY2017 | £4.5B | +23.4% |
| FY2016 | £3.6B | +1.9% |
| FY2015 | £3.6B | — |